Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where D. Tripodi is active.

Publication


Featured researches published by D. Tripodi.


International Journal of Immunopathology and Pharmacology | 2012

Nutrition and cancer prevention

Stefano Tetè; M. Nicoletti; A. Saggini; G. Maccauro; M Rosati; F. Conti; Cianchetti E; D. Tripodi; Elena Toniato; Mario Fulcheri; Vincenzo Salini; Auro Caraffa; P. Antinolfi; S. Frydas; Franco Pandolfi; Pio Conti; Gabriele Potalivo; Theoharis C. Theoharides

Cancer cells invade surrounding tissues and metastasize to distant sites. Diet high in fat is a strong link to, and perhaps causes, a high incidence of tumours. Trans-fatty acid might impair the function and it could be involved in the development of cancer. Cholesterol is also strongly suspected to be involved in the development of tumours, therefore it is important for everyone to eat well, especially for people with cancer to prevent the body tissues from breaking down and helping to rebuild the normal tissue that may have been affected by the treatments. Factors secreted by adipocytes and macrophages such as TNF-alpha and other inflammatory proteins are involved in inflammation in cancer. In addition, MCSF which up-regulates adipocyte tissue is also important for the stimulation of fat cell proliferation and is expressed by human adipocytes. Many cytokines, such as IL-1, IL-6, IL-8, IL-32, IL-33 and MCP-1, are biomarkers for cancer and chronic diseases along with transcription factors NFkB and AP-1; these last two factors are important bioactive substances on the molecular mechanism of the control of genes which in turn affect cellular metabolism. In this paper we revisit the interrelationship between cancer and metabolism.


International Journal of Immunopathology and Pharmacology | 2013

Vascular Endothelial Growth Factor (VEGF), Mast Cells and Inflammation

Y.B. Shaik-Dasthagirisaheb; G. Varvara; Giovanna Murmura; Andrea Saggini; Gabriele Potalivo; Auro Caraffa; P. Antinolfi; Stefano Tetè; D. Tripodi; F. Conti; Cianchetti E; Elena Toniato; M Rosati; Pio Conti; Lorenza Speranza; A Pantalone; Saggini R; Theoharis C. Theoharides; Franco Pandolfi

Vascular endothelial growth factor (VEGF) is one of the most important inducers of angiogenesis, therefore blocking angiogenesis has led to great promise in the treatment of various cancers and inflammatory diseases. VEGF, expressed in response to soluble mediators such as cytokines and growth factors, is important in the physiological development of blood vessels as well as development of vessels in tumors. In cancer patients VEGF levels are increased, and the expression of VEGF is associated with poor prognosis in diseases. VEGF is a mediator of angiogenesis and inflammation which are closely integrated processes in a number of physiological and pathological conditions including obesity, psoriasis, autoimmune diseases and tumor. Mast cells can be activated by anti-IgE to release potent mediators of inflammation and can also respond to bacterial or viral antigens, cytokines, growth factors and hormones, leading to differential release of distinct mediators without degranulation. Substance P strongly induces VEGF in mast cells, and IL-33 contributes to the stimulation and release of VEGF in human mast cells in a dose-dependent manner and acts synergistically in combination with Substance P. Here we report a strong link between VEGF and mast cells and we depict their role in inflammation and immunity.


International Journal of Immunopathology and Pharmacology | 2012

IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation.

Stefano Tetè; D. Tripodi; M Rosati; F. Conti; G. Maccauro; A. Saggini; Cianchetti E; Auro Caraffa; P. Antinolfi; Elena Toniato; M.L. Castellani; Pio Conti; Theoharis C. Theoharides

Cytokines such as interleukins, chemokines and interferons are immunomodulating and inflammatory agents, characterized by considerable redundancy, in that many cytokines appear to share similar functions. Virtually all nucleated cells, but especially epithelial cells and macrophages, are potent producers of cytokines. The objective of this study is to review the detailed mechanism of action and the biological profiles of IL-37, the newest anti-inflammatory cytokine. This review focuses on IL-37, a key cytokine in regulating inflammatory responses, mainly by inhibiting the expression, production and function of proinflammatory cytokines: IL-1 family pro-inflammatory effects are markedly suppressed by IL-37.


International Journal of Immunopathology and Pharmacology | 2011

Atherosclerosis: a classic inflammatory disease.

A. Anogeianaki; Angelucci D; Cianchetti E; D'Alessandro M; G. Maccauro; Andrea Saggini; Salini; Auro Caraffa; Stefano Tetè; F. Conti; D. Tripodi; Y.B. Shaik-Dasthagirisaheb

Atherosclerosis is an inflammatory disease due to a diet high in saturated fat, hypercholesterolemia, obesity, hypoglycemia, etc. mainly mediated by the infiltration of macrophage and T cells into the vascular wall. Once the endothelial is damaged monocytes penetrate the tissue and are transformed in scavenger cells. Upon stimulation of Th1 cells, a group of cytokines is released and contributes to the inflammatory response of atherosclerotic tissue. When macrophages proliferate they amplify inflammatory response through the secretion of growth factors and cytokines such as TNF and IL-1. In addition, chemokines such as RANTES and other C-C chemokines are generated, and matrix metalloprotinease 9 (MMP-9) are produced by activated monocytes. However, the immune system in atherosclerosis still remains unclear. Here, in this study we revisited the inter-relationship between atherosclerosis and inflammation.


International Journal of Immunopathology and Pharmacology | 2011

Allergic inflammation: role of cytokines with special emphasis on IL-4

A. Saggini; G. Maccauro; D. Tripodi; M.A. De Lutiis; F. Conti; Paolo Felaco; M. Fulcheri; R. Galzio; Auro Caraffa; P. Antinolfi; M. Felaco; Franco Pandolfi; Giuseppe Sabatino; G. Neri; Y.B. Shaik-Dasthagirisaheb

This review examines recent articles on the relationship of cytokines to allergy and inflammation with particular emphasis on interleukin (IL)-4. The objective of this article is therefore to review published studies to identify cytokines consistently involved in allergic inflammation. Proinflammatory cytokines, including IL-4, IL-5, IL-13 and GM-CSF along with TNF-alpha play a role in allergen-induced airway leukocyte recruitment and these cytokines can be generated by T mast cells and other cells. In addition, IL-9, IL-25, IL-33, IL-17, IL-27 and IFN-γ are deeply involved in the regulation of asthma. Blocking the effect of these proinflammatory cytokines might provide new therapeutic approaches for the control of allergy and inflammation.


International Journal of Immunopathology and Pharmacology | 2013

Impact of Capsaicin on Mast Cell Inflammation

S. Frydas; G. Varvara; Giovanna Murmura; Andrea Saggini; Auro Caraffa; P. Antinolfi; Stefano Tetè; D. Tripodi; F. Conti; Cianchetti E; Elena Toniato; M Rosati; Lorenza Speranza; A Pantalone; Saggini R; Lm Di Tommaso; Theoharis C. Theoharides; Pio Conti; Franco Pandolfi

Mast cells are inflammatory cells, and they are prominent in inflammatory diseases such as allergy and asthma. Mast cells possess high-affinity receptors for IgE (FCεRI) and the cross-linking of these receptors is essential to trigger the secretion of granules containing arachidonic acid metabolism [such as prostaglandin (PG) D2, leukotriene (LT) B4, and LTC4], histamine, cytokines, chemokines, and proteases, including mast cell-specific chymases and tryptases. Activation of mast cells provokes the secretion of cytokines and mediators that are responsible for the pathologic reaction of immediate hypersensitivity. Sensory nerve stimulation by irritants and other inflammatory mediators provokes the release of neuropeptides, causing an increase in vascular permeability, plasma extravasation and edema. Trigeminal nerve stimulation actives dura mast cells and increases vascular permeability, effects inhibited by capsaicin. Capsaicin causes release of sensory neuropeptide, catecholamines and vasodilation. Several studies have reported that capsaicin is effective in relief and prevention of migraine headaches, improves digestion, helps to prevent heart disease, and lowers blood cholesterol and blood pressure levels. The findings reported in these studies may have implications for the pathophysiology and possible therapy of neuroinflammatory disorders.


International Journal of Immunopathology and Pharmacology | 2012

Impact of neuropeptide substance P an inflammatory compound on arachidonic acid compound generation

M. Nicoletti; G. Neri; G. Maccauro; D. Tripodi; G. Varvara; Andrea Saggini; Gabriele Potalivo; M.L. Castellani; M. Fulcheri; M Rosati; Elena Toniato; Auro Caraffa; P. Antinolfi; Giuliano Giorgio Cerulli; Franco Pandolfi; R. Galzio; Pio Conti; Tc Theoharides

There is much evidence that neuropeptide substance P is involved in neurogenic inflammation and is an important neurotransmitter and neurmodulator compound. In addition, substance P plays an important role in inflammation and immunity. Macrophages can be activated by substance P which provokes the release of inflammatory compounds such as interleukins, chemokines and growth factors. Substance P is involved in the mechanism of pain through the trigeminal nerve which runs through the head, temporal and sinus cavity. Substance P also activates mast cells to release inflammatory mediators such as arachindonic acid compound, cytokines/chemokines and histamine. The release of these chemical mediators is crucial for inflammatory response. Among these mediators there are prostoglandins and leukotrines. Here we review the impact of substance P on inflammatory compounds.


International Journal of Immunopathology and Pharmacology | 2012

Endothelial cells, cholesterol, cytokines, and aging.

Stefano Tetè; D. Tripodi; M Rosati; F. Conti; G. Maccauro; A. Saggini; Salini; Cianchetti E; Auro Caraffa; P. Antinolfi; Elena Toniato; M.L. Castellani; Franco Pandolfi; S. Frydas; Pio Conti; Theoharis C. Theoharides

It has been reported that high levels of cholesterol and triglycerides are associated with increased risk of developing atherosclerosis and shorter life. In fact, vascular endothelial dysfunction occurs during the human aging process. Accumulation of lipids in vascular endothelium activates leukocytes to produce cytokines and chemokines which recruit macrophages. On the other hand, macrophages augment inflammatory response and secrete vascular endothelial growth factor, a key cytokine that mediates angiogenesis and inflammatory response. In addition, hyperlipidaemia is one of the main risk factors for aging, hypertension and diabetes. Here, we review the interrelationship between endothelial cells, high level of cholesterol, and aging.


International Journal of Immunopathology and Pharmacology | 2010

Vitamins and mast cells.

A. Anogeianaki; M.L. Castellani; D. Tripodi; Elena Toniato; M.A. De Lutiis; F. Conti; Paolo Felaco; M. Fulcheri; Theoharis C. Theoharides; R. Galzio; Auro Caraffa; P. Antinolfi; Chiara Cuccurullo; C. Ciampoli; Mario Felaco; Giuliano Giorgio Cerulli; Franco Pandolfi; Giuseppe Sabatino; G. Neri; Y.B. Shaik-Dasthagirisaheb

The immune system is a highly complex, intricately regulated group of cells whose integrated function is essential to health. The mast cell inflammatory response is characterized by an early phase with massive discharge of mediators stored in cytoplasmic secretory granules. Through multigranular/compound exocytosis and a late phase that involves generation of arachidonic acid metabolites and de novo synthesis of cytokines/chemokines and growth factors. Vitamins have been shown to have a protective effect on the bodys immune cells. Vitamin C and E are necessary in allergic disease treatment where mast cells are involved. In addition, ascorbic acid and pyridoxine are useful compounds for the treatment of inflammatory disorder of the respiratory airways. Here we revisited the inter-relationship between vitamins and mast cells.


International Journal of Immunopathology and Pharmacology | 2010

IL-31 a Th2 cytokine involved in immunity and inflammation.

M.L. Castellani; Paolo Felaco; R. Galzio; D. Tripodi; Elena Toniato; M.A. De Lutiis; M. Fulcheri; Auro Caraffa; P. Antinolfi; Stefano Tetè; Mario Felaco; F. Conti; Franco Pandolfi; Theoharis C. Theoharides; Y.B. Shaik-Dasthagirisaheb

Cytokines are immunal regulatory proteins, however they also play a relevant role in inflammatory diseases. IL-31 is a newly discovered cytokine expressed primarily in TH2 cells, introduced by activated CD4+ T cells. IL-31 is capable of inducing chemokines and other cytokines in several inflammatory diseases via its surface receptor. This cytokine is also produced by mast cells and mast cell line, suggesting a role in allergic diseases. In this editorial we revisit the biological role of IL-31 in immunity and inflammation.

Collaboration


Dive into the D. Tripodi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Stefano Tetè

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

G. Maccauro

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar

Franco Pandolfi

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar

Cianchetti E

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

Andrea Saggini

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

Pio Conti

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

M.L. Castellani

University of Chieti-Pescara

View shared research outputs
Researchain Logo
Decentralizing Knowledge